C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2011
11/01/2011	US8048984 Human GIL-19/AE289 proteins
11/01/2011	US8048983 HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells
11/01/2011	US8048854 Amidated insulin glargine
11/01/2011	US8048851 Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
11/01/2011	US8048850 Anticancer agents
11/01/2011	US8048849 Long-acting polypeptides and methods of producing same
11/01/2011	US8048848 Long-acting interferons and derivatives thereof and methods thereof
11/01/2011	US8048847 Derivatives of the IL-2 receptor gamma chain, their production and use
11/01/2011	US8048683 Insect repellent and process for identifying other insect repellent molecules
11/01/2011	US8048676 Systems of diagnosing cervical cancer
11/01/2011	US8048672 Comprises nucleotide sequences coding transcription factor for treating infections, multiple sclerosis, arthritis and autoimmune disease
11/01/2011	US8048664 Polynucleotides encoding modified DNA cleavage enzymes and host cells therefor
11/01/2011	US8048662 Sulfotransferase 1E1 sequence variants
11/01/2011	US8048646 NELL peptide expression systems and bone formation activity of NELL peptide
11/01/2011	US8048643 FRET protease assays for clostridial toxins
11/01/2011	US8048430 Influenza hemagglutinin and neuraminidase variants
11/01/2011	US8048427 Subgenomic replicons of the flavivirus dengue
11/01/2011	US8048424 Insect poison allergens with reduced IgE reactivity and method for producing the same
11/01/2011	CA2537880C Composition for protecting proteins degradation comprising small heat shock proteins (shsps) and method of two-dimensional gel electrophoresis using the shsps
11/01/2011	CA2494140C Specific antibodies for diagnosing heart failure
11/01/2011	CA2416097C Modified serum albumin with reduced affinity for nickel and copper
11/01/2011	CA2384416C System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse
11/01/2011	CA2379100C Methods for reducing the formation of byproducts in the production of recombinant polypeptides
11/01/2011	CA2374916C Diagnostics and therapeutics for cardiovascular disorders
11/01/2011	CA2366056C Non-spreading pestivirus
11/01/2011	CA2295986C Novel antimicrobial polypeptide and methods of use
11/01/2011	CA2235443C Novel insulin derivatives having a rapid onset of action
11/01/2011	CA2224626C Expression system employing a xylanolytic transcriptional activator
11/01/2011	CA2221192C Embedded expression of heterologous proteins
11/01/2011	CA2176942C Bmp-12, bmp-13 and tendon-inducing compositions thereof
11/01/2011	CA2105903C Methods and compositions for the detection of soluble .beta.-amyloid peptide
10/2011
10/27/2011	WO2011133658A1 Compositions and methods for targeting and delivering therapeutics into cells
10/27/2011	WO2011133512A1 Rtef-1 variants and uses thereof
10/27/2011	WO2011133429A1 Cancer-related glycopeptide epitopes, antibodies and methods of use
10/27/2011	WO2011133216A2 Mutant nis protein and uses thereof
10/27/2011	WO2011133105A1 Novel allergen
10/27/2011	WO2011132713A1 Lipid membrane structure with nuclear transferability
10/27/2011	WO2011132018A1 Novel self-assembling peptides and their use in the formation of hydrogels
10/27/2011	WO2011131896A2 Peptide derivatives, preparation thereof and uses thereof as vectors
10/27/2011	WO2011131789A1 A vaccine comprising inactivated cells of haemophilus parasuis bacteria of serotype 5
10/27/2011	WO2011131747A1 Chimeric polypeptides useful in proximal and dynamic high-throughput screening methods
10/27/2011	WO2011131720A1 New stabilizing agent for pharmaceutical proteins
10/27/2011	WO2011131703A1 Genetically modified sendai virus for treatment of tumours
10/27/2011	WO2011131674A1 Process for the production of cells which are capable of converting arabinose
10/27/2011	WO2011131671A1 Novel self-assembling peptides and their use in the formation of hydrogels
10/27/2011	WO2011131667A1 Cell suitable for fermentation of a mixed sugar composition
10/27/2011	WO2011131658A1 Phospholipid-enriched vesicles bearing tissue factor having haemostatic activities and uses thereof
10/27/2011	WO2011131646A1 Long-acting gastrin derivatives
10/27/2011	WO2011131600A1 Nucleic acid sequences of a fish virus and the use thereof
10/27/2011	WO2011131420A1 Biocatalytic oxidation process with alkl gene product
10/27/2011	WO2011130878A1 Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
10/27/2011	WO2011130858A1 Method for the identification of t cell epitopes
10/27/2011	WO2011130801A1 Wheat immunoreactivity
10/27/2011	WO2011106607A3 Subunit vaccines for herpes viruses and methods of use
10/27/2011	WO2011103567A3 Peptides and methods for inducing cell death
10/27/2011	WO2011071799A3 Purification of bivalirudin
10/27/2011	WO2011069227A8 Anti-microbial agent from paenibacillus sp. and methods and uses thereof
10/27/2011	WO2011068853A3 TREATMENT OF IgE-MEDIATED DISEASE
10/27/2011	WO2011059779A3 Ligand-targeted multi- stereoisomer peptide polymer conjugates and uses thereof
10/27/2011	WO2011046622A3 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
10/27/2011	WO2011040978A3 Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof
10/27/2011	WO2011038205A3 Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh
10/27/2011	WO2011038149A3 Methods of treating inflammation
10/27/2011	WO2010115589A8 Trivalent, bispecific antibodies
10/27/2011	WO2007141131A9 Microfluidic device for controlled aggregation of spider silk
10/27/2011	US20110265222 Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
10/27/2011	US20110265218 Soybean cultivar 90210442
10/27/2011	US20110265217 Soybean Cultivar 98331422
10/27/2011	US20110265216 Soybean Cultivar 1000682
10/27/2011	US20110265215 Soybean cultivar 1000681
10/27/2011	US20110265214 Soybean Cultivar 95330721
10/27/2011	US20110265213 Soybean Cultivar 90282601
10/27/2011	US20110265212 Soybean Cultivar 97032301
10/27/2011	US20110265211 Soybean Cultivar 94334045
10/27/2011	US20110265210 Soybean Cultivar 98164635
10/27/2011	US20110265209 Soybean Cultivar S090249
10/27/2011	US20110265208 Soybean cultivar s090245
10/27/2011	US20110265207 Soybean Cultivar 95062025
10/27/2011	US20110265206 Soybean cultivar s090246
10/27/2011	US20110265205 Soybean Cultivar S090248
10/27/2011	US20110265204 Soybean cultivar 93022415
10/27/2011	US20110265203 Soybean cultivar 94222415
10/27/2011	US20110265197 Signatures and PCDeterminants Associated with Prostate Cancer and Methods of Use Thereof
10/27/2011	US20110265195 Unique associated kaposi's sarcoma virus sequences and uses thereof
10/27/2011	US20110263975 Fluorescent probes having a polymeric backbone
10/27/2011	US20110263834 Simple Method for Simultaneous Removal of Multiple Impurities from Culture Supernatants to Ultralow Levels
10/27/2011	US20110263832 Site-specific modification of proteins through chemical modification enabling protein conjugates, protein dimer formation, and stapled peptides
10/27/2011	US20110263831 NUCLEAR FACTOR kappaB INDUCING FACTOR
10/27/2011	US20110263824 Modified biotin-binding protein
10/27/2011	US20110263823 Enhanced capacity and purification of protein by mixed mode chromatography in the presence of aqueous-soluble nonionic organic polymers
10/27/2011	US20110263822 Composition for the prophylaxis and treatment of hbv infections and hbv-mediated diseases
10/27/2011	US20110263820 Antibodies and processes for preparing the same
10/27/2011	US20110263816 Metallopeptide catalysts
10/27/2011	US20110263689 AKT Ligands and Polynucleotides Encoding AKT Ligands
10/27/2011	US20110263681 Organic Compositions to Treat Beta-ENaC-Related Diseases
10/27/2011	US20110263678 Inhibitors of tgf-r signaling for treatment of cns disorders
10/27/2011	US20110263585 Screening Assay for Insecticides
10/27/2011	US20110263517 Cytokines and Cytokine Receptors with Reduced Immunogenicity
10/27/2011	US20110263515 Capture agents and related compositions, methods and systems
10/27/2011	US20110263513 Pharmaceutical Being Used For Treating Cancer and Fibrosis Disease and the Composition and Uses Thereof

1 ... 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 ... 2916